William D. Kerns
Corporate Officer/Principal presso CAN-FITE BIOPHARMA LTD.
Profilo
William D.
Kerns was the founder of Synchroneuron, Inc. (founded in 2011) and served as the Chief Executive Officer.
He is also the founder of Accellient Partners LLC.
Currently, Dr. Kerns holds the position of Chief Executive Officer at Accellient Partners LLC.
Additionally, he is the Director at Ternus Pharma, Inc. and the Vice President-Drug Development at Can-Fite BioPharma Ltd.
Previously, Dr. Kerns worked as the Vice President-Drug Development at OphthaliX, Inc., and held the position of Principal at GlaxoSmithKline LLC and Eisai Pharmaceuticals India Pvt Ltd.
In terms of education, Dr. Kerns completed his undergraduate degree at The Ohio State University and obtained a doctorate from The Ohio State University College of Veterinary Medicine.
Dr. Kerns is also the founder of Accellient Partners LLC.
Posizioni attive di William D. Kerns
| Società | Posizione | Inizio |
|---|---|---|
| CAN-FITE BIOPHARMA LTD. | Corporate Officer/Principal | - |
Accellient Partners LLC
 Accellient Partners LLC Pharmaceuticals: MajorHealth Technology Accellient Partners LLC is a Pharmaceutical company. It offers integrated drug development, chemistry, manufacturing, and controls, nonclinical development, regulatory, clinical and start-up support. The company is headquartered in Waltham, MA. | Chief Executive Officer | - |
Ternus Pharma, Inc.
 Ternus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Ternus Pharma, Inc. operates as a biotechnology company. It develops enhanced general anesthetic. The company is headquartered in Duxbury, MA. | Director/Board Member | - |
Precedenti posizioni note di William D. Kerns
| Società | Posizione | Fine |
|---|---|---|
Eisai Pharmaceuticals India Pvt Ltd.
 Eisai Pharmaceuticals India Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Pharmaceuticals India Pvt Ltd. is an Indian company that manufactures and exports drug substances. The private company is based in Visakhapatnam, India. The company was founded in 2007. The CEO is Sanjit Singh Lamba. | Corporate Officer/Principal | - |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
OphthaliX, Inc.
 OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Corporate Officer/Principal | - |
Accellient Partners LLC
Accellient Partners LLC Pharmaceuticals: MajorHealth Technology Accellient Partners LLC is a Pharmaceutical company. It offers integrated drug development, chemistry, manufacturing, and controls, nonclinical development, regulatory, clinical and start-up support. The company is headquartered in Waltham, MA. | Founder | - |
Synchroneuron, Inc.
 Synchroneuron, Inc. Pharmaceuticals: MajorHealth Technology Synchroneuron, Inc. develops therapies for tardive dyskinesia (TD) and other neuropsychiatric disorders. It offers a novel treatment for movement disorders, utilizing a drug with simultaneous effects on excitatory and inhibitory neurotransmission. The company was founded by Kei-Lai L. Fong, William D. Kerns, Marc R. Cote and Barry S. Fogel in 2011 and is headquartered in Newton, MA. | Chief Executive Officer | - |
Formazione di William D. Kerns
| The Ohio State University | Undergraduate Degree |
| The Ohio State University College of Veterinary Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CAN-FITE BIOPHARMA LTD. | Health Technology |
| Aziende private | 6 |
|---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Eisai Pharmaceuticals India Pvt Ltd.
Eisai Pharmaceuticals India Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Pharmaceuticals India Pvt Ltd. is an Indian company that manufactures and exports drug substances. The private company is based in Visakhapatnam, India. The company was founded in 2007. The CEO is Sanjit Singh Lamba. | Health Technology |
Synchroneuron, Inc.
Synchroneuron, Inc. Pharmaceuticals: MajorHealth Technology Synchroneuron, Inc. develops therapies for tardive dyskinesia (TD) and other neuropsychiatric disorders. It offers a novel treatment for movement disorders, utilizing a drug with simultaneous effects on excitatory and inhibitory neurotransmission. The company was founded by Kei-Lai L. Fong, William D. Kerns, Marc R. Cote and Barry S. Fogel in 2011 and is headquartered in Newton, MA. | Health Technology |
Ternus Pharma, Inc.
Ternus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Ternus Pharma, Inc. operates as a biotechnology company. It develops enhanced general anesthetic. The company is headquartered in Duxbury, MA. | Health Technology |
Accellient Partners LLC
Accellient Partners LLC Pharmaceuticals: MajorHealth Technology Accellient Partners LLC is a Pharmaceutical company. It offers integrated drug development, chemistry, manufacturing, and controls, nonclinical development, regulatory, clinical and start-up support. The company is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- William D. Kerns
